C. Russell Trenary III

2021

In 2021, C. Russell Trenary III earned a total compensation of $7.5M as President and Chief Executive Officer at Outlook Therapeutics.

Compensation breakdown

Option Awards$7,304,000
Salary$145,384
Other$6,228
Total$7,455,612

Trenary received $7.3M in option awards, accounting for 98% of the total pay in 2021.

Trenary also received $145.4K in salary and $6.2K in other compensation.

Rankings

In 2021, C. Russell Trenary III's compensation ranked 1,592nd out of 12,415 executives tracked by ExecPay. In other words, Trenary earned more than 87.2% of executives.

ClassificationRankingPercentile
All
1,592
out of 12,415
87th
Division
Manufacturing
579
out of 5,505
90th
Major group
Chemicals And Allied Products
214
out of 2,375
91st
Industry group
Drugs
179
out of 2,096
92nd
Industry
Biological Products, Except Diagnostic Substances
49
out of 449
89th
Source: SEC filing on January 27, 2022.

Trenary's colleagues

We found three more compensation records of executives who worked with C. Russell Trenary III at Outlook Therapeutics in 2021.

2021

Lawrence Kenyon

Outlook Therapeutics

Chief Financial Officer

2021

Terry Dagnon

Outlook Therapeutics

Chief Operations Officer

2021

Jeff Evanson

Outlook Therapeutics

Chief Commercial Officer

News

In-depth

You may also like